Altavo Raises €5M in Series A Funding to Revolutionize Voice Rehabilitation with AI-Based Technology
Altavo is pioneering in the field of voice rehabilitation through its innovative Artificial Voice device.
Company Name: Altavo
Location: Dresden and Jena, Germany
Sector: AI-Based Voice Rehabilitation
Funding Details: Raised €5M in Series A funding, led by Occident, with participation from Novalis Biotech, Beteiligungsmanagement Thüringen, TGFS Technologiegründerfonds Sachsen, High-Tech Gründerfonds (HTGF), Saxonia Systems Holding, and TUDAG TU Dresden AG.
Purpose of Investment: To accelerate growth, product development, pivotal clinical trial, and internationalization.
Leadership: CEO Rudolf von Bünau
Product: Artificial Voice, a medical device aimed at helping voiceless individuals, such as those post-laryngectomy or during mechanical ventilation, to regain their natural sounding voice. The technology utilizes non-invasive radar sensing and advanced neural network architectures, developed in collaboration with Technical University Dresden.
About Company: Altavo is pioneering in the field of voice rehabilitation through its innovative Artificial Voice device. This groundbreaking technology offers hope and practical solutions for individuals who have lost their ability to speak, providing them with a means to regain a natural sounding voice.